Interestingly, and in line with previous observations carried out in pancreatic cancer cells [39], we also showed that the CB2 receptor inhibitors dampened the BCP-dependent stimulation of GAPDH activities and downstream enzymes enolase and PK. Here, OPN1SW is linked to pancreatic neoplasm.